LN-757914
Dulaglutide , 98% , 923950-08-7
Update time: 2023-04-23
PRODUCT Properties
| form | Liquid |
| color | Colorless to light yellow |
Description and Uses
Dulaglutide, a GLP-1 receptor agonist that is administered subcutaneously once weekly, has been approved since 2014 for the treatment of adults with type 2 diabetes.